Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis.
about
My approach to the treatment of sclerodermaThe clinical relevance of autoantibodies in sclerodermaRaynaud's phenomenon and digital ischemia: a practical approach to risk stratification, diagnosis and managementAnticardiolipin, anticentromere and anti-Scl-70 antibodies in patients with systemic sclerosis and severe digital ischaemia.Increased prevalence of symptomatic macrovascular disease in systemic sclerosisDistinct recognition of antibodies to centromere proteins in primary Sjogren's syndrome compared with limited scleroderma.Altered autoantigen structure in Sjögren's syndrome: implications for the pathogenesis of autoimmune tissue damage.Anti-Interferon-Inducible Protein 16 Antibodies Associate With Digital Gangrene in Patients With Scleroderma.Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study.Digital gangrene associated with anticentromere antibodies.Anti-centromere antibodies as a marker of Raynaud's phenomenon in pediatric rheumatologic diseases.Recognition of Granzyme B-generated autoantigen fragments in scleroderma patients with ischemic digital loss.Digital gangrene associated with anticentromere antibodies: a case report.Digital ischemic loss in systemic sclerosis.A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis.A longitudinal study of ankle brachial pressure indices in a cohort of patients with systemic sclerosis.Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series.Risk of Digital Vascular Events in Scleroderma Patients Who Have Both Anticentromere and Anti-Interferon-Inducible Protein 16 Antibodies.Vascular Evaluation of the Hand by Power Doppler Ultrasonography and New Predictive Markers of Ischemic Digital Ulcers in Systemic Sclerosis: Results of a Prospective Pilot Study.A synonymous variant in TREX1 is associated with systemic sclerosis and severe digital ischaemia.History of surgical debridement, anticentromere antibody, and disease duration are associated with calcinosis in patients with systemic sclerosis.Autoantibodies in systemic sclerosis.A review of the possible health implications of silicone breast implants.Enrichment of Scleroderma Vascular Disease-Associated Autoantigens in Endothelial Lineage Cells.Modeling smoking in systemic sclerosis: a comparison of different statistical approaches.Abnormal exhaled ethane concentrations in scleroderma.Quantitation of microcirculatory abnormalities in patients with primary Raynaud's phenomenon and systemic sclerosis by video capillaroscopy.Isolated digital infarction associated with anticentromere antibody.[Critical limb ischemia in systemic sclerosis].The effects of upper and lower limb exercise on the microvascular reactivity in limited cutaneous systemic sclerosis patients.
P2860
Q24618843-035183B0-1C09-48D3-BA8F-6695FB02A456Q24682842-C26E7A6C-5393-4A5C-8E8E-89E0BDE706EEQ28392431-ABEDACC5-E230-4366-8714-E6E22A653CE0Q33566574-FB6DE8E1-1724-42BC-98C2-0955A44EA5CFQ33578449-E3C87F45-40EE-4A09-A4FC-30EA5BB5B949Q35637527-567CABF4-8D7C-4D6A-A52C-B30530F039B8Q35798719-A4D11A49-AB4A-4F79-87BC-D851AF673583Q36844687-87407E22-E29F-407C-9506-7AC9D58D8467Q37351603-6047D86B-8DE8-4E38-ACAE-D35A85B107CEQ37690928-9EEB7EA9-694B-4B50-9D4C-0CD16A3BA127Q38557487-57934B8E-94DC-404F-9DF3-5B455E313638Q39553952-94BD183F-F772-48A7-92F6-F7468E97DC2AQ39608534-9C583BFE-3B4C-4A0A-9877-6A8E52DF87A6Q39938714-AD1ED85B-BAAA-4BBD-8BD1-0E87E64D007AQ39952395-5AF52581-58FB-43A8-BD87-293F59D96CC5Q39955870-FA40C089-49E1-4C52-91B3-62D239D0A5E8Q40198680-86484554-077F-4501-8996-5102580F7B51Q40371203-0B3F3062-35C6-4EBC-8BB3-CBFAA5D55FB2Q40387800-34500BC1-FF87-4CFC-8507-DCCCDCE206D1Q40387840-8FB73441-58CC-4F51-95A3-52FBCC1991FDQ40401167-A45B3AD6-3C85-4554-8C2D-03F1CF50035AQ40453045-8AEB6D27-D837-4B2B-A187-EA436D1484E6Q40468520-E946B9E4-EE5F-4D3F-9226-A0E3BDECBB29Q41453554-C1F1C88C-A14A-43F7-95E2-7C4365AB0B59Q41633177-E9F06709-D3AA-4027-AF18-083BCC10F940Q46079535-53C27DFB-6E17-4C29-91F4-3EE40B032D63Q46949329-ADB68F7A-7731-474B-9E84-34A77684E5C9Q47590489-465EA232-DE2C-40C0-872F-CA7E06D0D9A1Q48537509-2AE792FF-B875-4F76-BA63-80B8D77F667FQ52888539-D80278CA-DADC-46F0-90DF-47E237E855B8Q55414991-713CB1D3-384F-49BF-8A33-13D12326DB0A
P2860
Anticentromere antibody as a predictor of digital ischemic loss in patients with systemic sclerosis.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Anticentromere antibody as a p ...... ients with systemic sclerosis.
@ast
Anticentromere antibody as a p ...... ients with systemic sclerosis.
@en
type
label
Anticentromere antibody as a p ...... ients with systemic sclerosis.
@ast
Anticentromere antibody as a p ...... ients with systemic sclerosis.
@en
prefLabel
Anticentromere antibody as a p ...... ients with systemic sclerosis.
@ast
Anticentromere antibody as a p ...... ients with systemic sclerosis.
@en
P2093
P356
P1476
Anticentromere antibody as a p ...... ients with systemic sclerosis.
@en
P2093
P2860
P304
P356
10.1002/ART.1780350614
P577
1992-06-01T00:00:00Z